“Interim Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes” (2022) SKIN The Journal of Cutaneous Medicine, 6(6), pp. 458–462. doi:10.25251/skin.6.6.2.